The first observations supporting a correlation between injury to the central nervous system (CNS; . Fig. 1 ) and reduced immune function were made as early as in the 1970s [5] . Since then, numerous detailed studies have been published reporting a suppression of the immune system following brain injury, in particular after stroke or head injury [26, 41] . However, the increased incidence of infection observed following spinal cord injury continued to be considered an accessory symptom of organ dysfunction alone in paraplegic patients: The increased incidence of urinary tract infections was attributed to the transport of bacteria into the bladder via catheterisation, while increased susceptibility to lung infection was accounted for by atelectases and/or mechanical ventilation in many paraplegic patients. Although an ablative immune response (of both natural and adaptive immunity) was also described following spinal cord injury [4, 3] , this was interpreted as a general stress response, occurring solely due to the increased release of stress hormones over an extended period of time.
In contrast, during the last two decades increasing evidence revealed that both immunosuppression and the incidence of infection were much more pronounced following CNS injury than could be explained with general stress responses (post-aggression syndrome) alone, as seen for example following cardiac infarction or as part of multiple trauma. The "neurogenic" syndrome of immunosuppression after injury to the CNS was first integratively described as a pathoimmunologic entity in 2005 [20] .
From 1990 up to around 2005 following spinal cord injury the non-evidencebased standard therapy included highdose glucocorticoids, such as methylprednisolone or corticosterone. Therefore it remained elusive whether the symptoms observed could be attributed to the body's own reaction or to the iatrogenic consequences of treatment. In the pioneering work of Riegger et al. [28, 29] , however, it could be shown that even in animal experiments without the use of glucocorticoids there is a drastic reduction in cell count in almost all leukocyte populations following spinal cord injury. The results of this work are in line with the observations made in paraplegic patients [30] . Moreover, the cellular composition and corresponding time window of the syndrome could be demonstrated for the first time. Injury to the spinal cord can affect both the white and grey substance and hence, according to the level of the lesion, directly damage the sympathetic (thoracolumbar, Th1-L3) and/or parasympathetic (sacral, S2-4) nervous system (preganglionic damage) located in the myelon (1). Moreover, neighbouring structures, such as spinal efferents (2) or the sympathetic trunk (3) are often damaged. The nerves leading to the celiac ganglion at Th5-Th9 provide the main innervation of immunologically relevant organs such as the spleen. The underlying nerves contribute only scantly to this innervation (Th10-12). Injury above this level therefore affects immunosuppression following spinal cord injury in a different way to injury below this level
Although now generally accepted and independently reproduced, it remains unclear why spinal cord injury leads to systemic immunosuppression (spinal cord injury-induced immune depression syndrome, SCI-IDS; [25, 28] ), how this is mediated and in what way it affects the regeneration of destroyed nerves and neurofunctional changes.
Clinical significance
Whereas in the beginning of the last century the majority of patients died as a direct result of their injuries, the survival rate of patients with acute spinal cord injury has been drastically increased over the last 60 years from 5% to 95% [32] . At present, however, infection is the main cause of death in the post-acute phase following spinal cord injury [6, 8] . In particular, the likelihood of pneumonia and urinary tract infection is increased in the initial days following injury [15, 40] . Thus, as a result of a reduced immune status, spinal cord injury leads to increased mortality primarily unrelated to the injury. Since the costs of primary care and rehabilitation of approximately 150,000 Euro per patient are increased to over 200,000 Euro annually as a result of the above-mentioned complications [32] , immunosuppression following spinal cord injury are of socioeconomic relevance especially in times of shrinking health care resources. Infections lead to higher frequence and longer periods of hospitalization.
Although it appears that immunosuppression (characterised on a cellular level; . Fig. 2 ) following spinal cord injury leads to increased susceptibility to infection, it remained elusive how many infections are attributable exclusively to immunosuppression. It should be mentioned in this context that CNS injury represents an independent risk factor for the development of infection in multiple trauma patients. Experimental infection models support a direct association between susceptibility to infection and CNS injury. Thus is could be shown in a mouse stroke model, for example, that a thousand-fold smaller number of pneumococci was sufficient to trigger lung infection [26] . 4 9 Information pathways between the CNS and the immune system. CNS and the immune system connect various information paths, both humoral and neurogenic, the most important of which are shown here Initial findings indicate that infections, facilitated by a spinal cord injury triggered secondary immunodeficiency might restrict improvements in neurological function (recovery).This points to an inverse correlation between infections and neurofunctional improvement. A large systematic epidemiological study (n 2300 patients) showed that functional neurological recovery in paraplegic patients with documented infection is limited. Patients without documented infection showed significantly greater improvement (Failli et al., unpublished data).
Cellular effects of immunosuppression
The cellular manifestation of immunosuppression following spinal cord injury has been characterized both in humans and rodents (. Fig. 3 ): immediately following injury, the monocytic cell count, B-and Tlymphocyte cell count, as well as the dendritic cell count in peripheral blood drop significantly [29, 30] . Concomitant to this, there is a profound increase in the leukocyte apoptosis in the spleen [16] . In addition, reduced lymphocyte proliferation [3] and reduced natural killer cell and T-lymphocyte function [4] , as well as reduced B-lymphocyte functionality, have been reported [16] .
Underlying mechanisms
At least three different information pathways by which the CNS signals to and the immune system are known to date: On the one hand, the sympathetic nervous system (SNS) and the parasympathetic nervous system (PSNS), and on the other, activation of the hypothalamo-pituitary glandadrenal gland axis (HPA axis). The first two use adrenaline and other catecholamines (SNS) or acetylcholine (PSNS) as neurotransmitters, while the HPA axis triggers the release of glucocorticoids, such as cortisol (. Fig. 4 ). In addition to their role as neurotransmitters, they exert an immunomodulatory effect after binding directly to corresponding leukocyte membrane receptors [20] .
Investigations in animal models in which the above-mentioned information pathways were blocked in order to moni- 
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tor the differential effect on the immunosuppression clearly showed that the SNS has a marked effect in this context, particularly in the early phase: SNS blockade completely reconstituted immunosuppression-attenuated antibody production, while SNS stimulation had the opposite effect [16] . There was also a synergistic effect on simultaneous blockade of both cascades (SNS and HPA axis) in vivo in terms of a reduction in the rate of spleen cell apoptosis [17] . This joint effect of SNS and HPA axis were characterised by means of in vitro investigations: both glucocorticoids and β2-andrenoceptor agonists (β2-AR, an important receptor of the SNS) induced apoptosis of purified B-or T-lymphocytes. In B-lymphocytes in particular, a strong cumulative effect can be seen when both substances are used together. Lucin et al. [17] explain this with the interplay between the catecholamine noradrenaline (NE) and glucocorticoids (GC): NE causes increased stability in GC receptors and stronger binding to DNA. Conversely, GCs cause higher expression and affinity of NE receptors (β2-AR) and prevent downregulation of the same. On the basis of this, the authors postulate a hypersensitivisation of β2-ARs as a result of spinal cord injury [17] . Further support for a combined effect of these two in-vivo acting information pathways (SNS and HPA axis) on immunosuppression following spinal cord injury is seen in raised cortisol levels in the urine of spinal cord injury patients [4, 2] , which persist for up to 2 months [3] , as well as the observation of partially raised adrenaline and noradrenaline values [21] . The latter is mainly seen in patients with injury above Th6 level, in whom bladder and bowel evacuation causes a reflex-like release of noradrenaline [1] . Animal studies demonstrated that glucocorticoid concentrations following spinal cord injury were increased, while increased levels of noradrenaline were only seen in cases where the injury was above the sympathetic innervation of the spleen (see also . Fig. 5 ).
This illustrates the importance which of injury level along the spinal cord has on the extent of immunosuppression. Injury above the mesenteric plexus affects sympathetic innervation of important secondary immunological organs, such as the spleen and abdominal lymph nodes, as well as the adrenal cortex (. Fig. 5) . One of the first studies on immune response following spinal cord injury in humans was able to demonstrate that only injuries above the sympathetic innervation of the spleen (>Th10) lead to reduced phagocytic capacity of circulating neutrophils [3] .
The first patient studies with strongly varying injury levels make no distinction between spinal cord injury with and without disrupted sympathetic innervation of the spleen. The above-mentioned and observed differences on a cellular level suggest that injury level also affects clinically relevant susceptibility to infection. Following these lines, further systematic investigations of immunosuppression following spinal cord injury are necessary. They always should be performed taking possible differences in terms of lesion levels above or below the sympathetic innervation of the spleen into account.
Neurogenic immunosuppression-an evolutionary role?
One general question which arises with regard to the underlying mechanisms of immunosuppression following CNS injury is whether we are dealing with a useful evolutionary shaped development, i.e., a "desired" effect, or rather a dysfunction (functio laesa).
On the one hand, the immunosuppression could be the result of an evolutionary development aimed at preventing autoimmunity, which is then putatively directed against CNS components exposed during . These interact in a way that leads to higher receptor expression/stability in the other, amplifying the extent of the triggered immunosuppression. This mechanism could independent of spleen innervation and could be triggered, for example, by vegetative dysfunction due to bladder/bowel evacuation, among others injury. In this case, it is possible that the active and desired suppression of the immune system takes place according to the same mechanisms in all CNS injuries.
The extent to which an evolutionary process following CNS injury is possible remains fundamentally unexplained, since one cannot assume that, before the times of sophisticated intensive medical care, patients had significant numbers of offspring following stroke, head injury or spinal cord injury (even today this would be an exception). Therefore, one can assume only a small effect of evolutionary and genetic pressure. On the other hand, current interventional experiments show that denervation of afferent, sympathetic fibres triggers CNS immune privilege and propagates lesional CNS immune responses [38] . In this context, directional, counteractive, systemic immunoablation could be considered in order to avoid autoimmunity directed against antigens which, under physiological conditions, remain to a great extent immunologically hidden behind the blood-brain barrier. Until explained, the risk of a potential autoimmune reaction when attempting drug immunosuppression remains.
If immunosuppression has not developed in an evolutionary manner, but rather as a dysfunction within the CNS (immune paralysis), it can be assumed that varying forms and mechanisms could underlie different CNS injuries. Experiments have yielded evidence that there are distinct heterotypical inflammatory responses following brain injury compared to those following spinal cord injury [31] . The tendency not to differentiate between different, context specific CNS injury induced inflammatory responses have been heavily criticized [9] .
Immunosuppression following stroke-a model comparison
To date stroke is the best investigated CNS lesion model in terms of CNS-injury-induced immunodeficiency syndrome (CI-DS) thanks to the decisive contributions made by the Meisel brothers [20] . Due to their dependence on localisation, however, experimental stroke models are restricted in the extent to which they can be differentially investigated. There is an association with infarct size; however, attribution to affected vegetative centres of the brain (hypothalamus) is difficult. Thus spinal cord injury offers analytically accessible lesions of comparable size at varying lesion levels along the neuraxis, enabling the investigation of neuroanatomically defined pathophysiological associations (preganglionic damage to sympathetic spinal neurons). Investigations such as the blockade of various information pathways between the CNS and the immune system following spinal cord injury have also been performed following stroke. While it could be shown that the sympathetic nerve system plays a significant role here, no effect could be seen on HPA-axis blockade [26] .
Altogether, there are varying, although possibly complementary, hypotheses on the mechanisms of immunosuppression following CNS injury which are relevant to spinal cord injury. One hypothesis, for example, is the assumption of a disrupted regulating mechanism (. Fig. 6 ) which, under normal conditions, would suppress a prevailing inflammatory response as soon as CNS receptors detect excessively high cytokine concentrations, but which as a result of CNS injury "downregulates" the immune system even without peripheral inflammation, much in the sense of a "faulty reflex" [36] . To what extent this plays a role in spinal cord injury remains to be clarified.
As mentioned earlier, an as yet unpublished study shows a direct correlation between infection and reduced neurofunctional recovery following spinal cord injury (Vieri Failli, personal communication).
Thus the question arises as to how peripheral infections affect the CNS and can lead to a neurological deterioration. Additional investigations into other CNS injuries and neurodegenerative diseases could provide information. Experimental models were able to show that not only local but also systemic inflammatory reactions affect the development of this type of disease. Triggering systemic infection in animals with a chronic, neurodegenerative disease lead to a stronger inflammatory response in the brain, as well as to a significant increase in acute neurodegeneration. Some authors attributed this to macrophages that would already be activated by the CNS damage (primed macrophages) and therefore, as a reaction to the systemic infection, would change their phenotype and produce neurotoxic molecules [22] . Thus, cytokines would not be toxic per se, but they would significantly exacerbate neuronal damage if nerves were already damaged [23] . These concepts were developed in the context of neurodegenerative diseases such as Alzheimer's and multiple sclerosis; however, the question arises as to whether macrophages would also be primed following CNS injury and systemic infections would cause greater CNS injury. Clinical findings support neurodegeneration propagated by systemic infection and suggest a direct, neurofunctional effect relevant for Alzheimer patients for example [11] .
Normal condition CNS injury
Fig. 6 8 A disrupted regulatory mechanism ("reflex") as the cause of immunosuppression. While under normal conditions only the high cytokine concentration of an uncontrolled peripheral inflammatory response leads to immunosuppression by the CNS, a lower cytokine concentration in the CNS following CNS injury can trigger this kind of mechanism Investigations were carried out not only following neurodegenerative diseases, but also following CNS injury such as stroke. Thus it could be shown that the administration of lipopolysaccharide (LPS) as an infection model in the context of a stroke model in mice caused significantly increased neurological deficits [18] . The observation that the administration of interleukin-1 (IL-1) produced the same effect, while the administration of an IL-1 receptor antagonist caused a reversal of the effect following LPS administration shows that this mechanism is directly dependent on IL-1. It can be assumed that, also following spinal cord injury, similar mechanisms contribute to worsened neurofunctional recovery due to infection.
Based on results from stroke research and taking the differences in paraplegic injury into consideration as well as the results from current spinal cord research, we conclude that immunosuppression following spinal cord injury takes places according to the following mechanism:
Immediately following injury, and as a result of nerve injury (deafferentation response of the nerve endings), there is a sudden and drastic increase in catecholamine concentrations in serum as well as in the vegetatively innervated secondary lymphoid tissue itself ("sympathetic storm"). This is affected by means of a dysfunction in the autonomic nervous system, which transmits signals via afferent nerves into sympathetic ganglions, which are no longer connected to the brain and therefore escape cerebral control. The extent of this effect depends on the level of the injury. Furthermore, it leads to a massive non-neurogenic, that is to say non-localisation-related, release of adrenaline due to pain and stress directly following the accident (generalized stress response in the context of post-aggression syndrome). In the further course, and independent of localisation, the release of adrenaline can be repeated, triggered by vegetative dysfunction as a result of bladder/bowel evacuation (. Fig. 5 ). This leads to suppression of the immune system by the sympathetic nervous system. A further component is possibly the active suppression of the immune system by the parasympathetic nervous system due to cytokines in the injured CNS that feign uncontrolled peripheral inflammation. In addition to all these mechanisms, there is also a sensitization of SNS receptors, which is triggered by activation of the HPA axis and which amplifies the effect. Systemic immunosuppression is responsible for peripheral infection, which ironically causes a worsening of inflammation within the CNS due to the release of inflammatory cytokines, and thus to further neurological deterioration.
New treatment perspectives
There have been various approaches in recent years developed to better treat the immunosuppression and/or its consequences following CNS injury, in terms of both basic research and patient studies. Several studies investigated the prophylactic administration of antibiotics following stroke (e.g., [10] ), after promising results had been observed in animal studies. For example, the administration of Moxifloxacin in mice following stroke not only reduced mortality, but also improved neurological function [19] . However, although prophylactic administration was able to reduce the incidence of infection in stroke patients, none of the studies was able to demonstrate a significant reduction in mortality or improvement in neurofunction (for a systematic review of these studies see [37] ). The possibility of induced resistance to antibiotics as a result of this type of treatment also represents a problem. This also raises questions about the extent to which a purely antibiotic-based therapy would be sufficient and whether intervention in the immunosuppression mechanism is not also required in order to achieve a therapeutic improvement.
Another approach in the treatment of immunosuppression which has hitherto only been investigated in animals is the blockade of various information pathways between the CNS and the immune system as mentioned above. Tests to inhibit immunosuppression with β-blockers in mice were very successful. However, the high concentrations used in animals would probably have had dramatic side effects in humans. It should also be pointed out that the effect of blockade on various information pathways in animals with spinal cord injury was only investigated in terms of certain cellular aspects and not in terms of any clinically relevant reduction in susceptibility to infection.
Thus there are no simple, complication-free approaches to the treatment of immunosuppression yet. The advisability of the standard high-dose methylprednisolone therapy used in spinal cord patients in the past appears even more questionable against the background of our better understanding of immunosuppression, since the administration of glucocorticoids is proven to increase both mortality and strengthen immunosuppression [13, 35] . While methylprednisolone still largely represents the standard therapy following spinal cord injury in the US, its use in Canadian clinics is often dispensed with, while in Europe there is no consensus on its use.
The question arises as to whether a generalized, non-specific antagonization of immunosuppression also represents a risk (. Fig. 7 ). As mentioned above, this is also seen as possible protection against autoimmunity. In general, when answering the question of whether the positive or the negative effects prevail on immunosuppression deactivation, both systemic and local components need to be taken into consideration. The direct and probably only systemic effect of immunosuppression is increased susceptibility to infection, which often leads to complications and even death. The precise effects on the inflammatory reaction at the site of injury itself, on the other hand, are not well understood. It is possible that the inflammatory response without suppression would be far more drastic and would cause significant secondary damage. In this case, optimal treatment of systemic immunosuppression should include simultaneous local containment of the inflammatory response. On the other hand, it has been assumed by many in the past that an increased immune reaction at the injury site could be beneficial. Thus it was suggested that immunity has regenerative effects on injured nerves [34] , and that artificially introducing immune cells to the injury had a neuroprotective effect [27, 33] . Deploying the immune system in a targeted fashion against growth inhibitors was also considered [12] . However, it is estab-lished that not only are there multiple reports on the neuroprotective effects of immune cells at the injury site, but also many investigations in which a neurofunctional improvement could be achieved by blocking, eliminating or neutralizing immune cell. In their reviews Popovich and colleagues provide a good overview of the possible destructive effects of inflammation on the one hand and neuroprotective effects on the other [24] .
A deeper understanding of the underlying mechanisms of spinal cord injury triggered systemic immunosuppression classified as a novel spinal neurogenic syndrome is all the more important in order to selectively permit desired immunity to avoid the outcome of relevant infections, while inhibiting undesired immune responses (autoimmunity).
Conclusion
Spinal cord injury not only causes sensory motor paralysis, but also immune paralysis depending on the localization of the lesion. Onset of this secondary immunosuppression, i.e., SCI-IDS, is immediately following injury and, as shown in animal studies, irrespective of patients' treatment with methylprednisolone or other glucocorticoids. It is significantly stronger than normal stress reactions and is characterised cellularly in particular by a drastic reduction in almost all important leukocyte subpopulations. Thus it affects both congenital and adaptive immunity. The roles of the sympathetic nervous system and the HPA axis as main underlying mechanisms attributable to the composite neurosyndrome SCI-IDS have not been defined as yet. Irrespective of the extent and underlying mechanisms of immunosuppression, all CNS injuries result in increased susceptibility to infection. This leads not only to increased mortality, but possibly also correlates with neurofunctional deterioration. Likewise, studies have shown that systemic infection following ischemic (stroke) and traumatic (craniocerebral injury) brain damage, as well as neurodegenerative diseases, is associated with increased neurodegeneration [ 8 7 An immunobiological vicious circle following spinal cord injury. Since spinal cord injury results in increased infection due to suppression of the immune system, which in turn contributes to exacerbated neurodegeneration, a deterioration in neurofunction far beyond the extent of the original injury will necessarily result unless intervention is undertaken against immunosuppression cord injury, which would explain why immunosuppression results in a deterioration in neurofunction (. Fig. 8 ).
The establishment of predictive surrogate parameters appears to be necessary in order to preventively treat those patients specifically identified as high-risk in order reduce mortality and protect the intrinsic plasticity potential.
